63 related articles for article (PubMed ID: 3201898)
1. Cell growth kinetics of cultured human myeloma cell lines, KMM-1 and KMS-5.
Ohtsuki T; Yawata Y; Namba M
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1052-8. PubMed ID: 3201898
[No Abstract] [Full Text] [Related]
2. [Establishment and characterization of five human myeloma cell lines].
Ohtsuki T; Yawata Y; Namba M
Hum Cell; 1989 Sep; 2(3):297-303. PubMed ID: 2519219
[TBL] [Abstract][Full Text] [Related]
3. Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.
Otsuki T; Hata H; Harada N; Matsuzaki H; Yata K; Wada H; Yawata Y; Ueki A; Yamada O
Int J Hematol; 2000 Aug; 72(2):216-22. PubMed ID: 11039672
[TBL] [Abstract][Full Text] [Related]
4. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
5. [Effect of MCNU on growth kinetics of human plasma cell lines--in comparison with melphalan].
Ohnaka T; Ohno T; Kanoh T; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):971-7. PubMed ID: 3434146
[No Abstract] [Full Text] [Related]
6. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
7. [The mechanisms of myeloma cell growth].
Shimizu S
Nihon Rinsho; 1995 Mar; 53(3):557-63. PubMed ID: 7699885
[TBL] [Abstract][Full Text] [Related]
8. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
9. Dual regulatory effects of monocytes-macrophages on the proliferation of myeloma cells.
Shimizu S; Yoshioka R; Sugai S; Takiguchi T; Konda S
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1550-7. PubMed ID: 2470229
[No Abstract] [Full Text] [Related]
10. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
[TBL] [Abstract][Full Text] [Related]
11. [Cell division mechanism of multiple myeloma].
Shimizu S
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1055-60. PubMed ID: 7561358
[No Abstract] [Full Text] [Related]
12. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.
Ro TB; Holt RU; Brenne AT; Hjorth-Hansen H; Waage A; Hjertner O; Sundan A; Borset M
Oncogene; 2004 Apr; 23(17):3024-32. PubMed ID: 14691444
[TBL] [Abstract][Full Text] [Related]
14. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
15. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
Takahashi T; Okuno Y; Ohsugi Y
Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
[TBL] [Abstract][Full Text] [Related]
16. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
17. The synthetic furanonaphthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells.
Desmond JC; Kawabata H; Mueller-Tidow C; Simamura E; Heber D; Hirai K; Koeffler HP
Br J Haematol; 2005 Nov; 131(4):520-9. PubMed ID: 16281944
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
19. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
20. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
